143 related articles for article (PubMed ID: 38564774)
1. The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance.
Li MM; Baranwal A; Gurney M; Shah SN; Al-Kali A; Alkhateeb HB; Foran JM; Arana-Yi C; Ongie L; Chen D; Mangaonkar AA; McCullough K; Tefferi A; Lasho TL; Finke CM; Patnaik MM; Shah MV
Blood Adv; 2024 Apr; ():. PubMed ID: 38564774
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological features of clonal cytopenia of undetermined significance presenting with isolated thrombocytopenia (CCUS-IT).
O'Neill C; Nwachukwu N; Vergara-Lluri M; Hagiya A; O'Connell CL
Eur J Haematol; 2024 Apr; 112(4):594-600. PubMed ID: 38088145
[TBL] [Abstract][Full Text] [Related]
3. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
Cargo C; Bernard E; Beinortas T; Bolton KL; Glover P; Warren H; Payne D; Ali R; Khan A; Short M; Van Hoppe S; Smith A; Taylor J; Evans P; Papaemmanuil E; Crouch S
Lancet Haematol; 2024 Jan; 11(1):e51-e61. PubMed ID: 38135373
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms.
Shah MV; Mangaonkar AA; Begna KH; Alkhateeb HB; Greipp P; Nanaa A; Elliott MA; Hogan WJ; Litzow MR; McCullough K; Tefferi A; Gangat N; Patnaik MM; Al-Kali A; He R; Chen D
Blood Cancer J; 2022 Jul; 12(7):106. PubMed ID: 35803921
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome.
Choi EJ; Cho YU; Hur EH; Park HS; Choi Y; Lee JH; Lee KH; Kim M; Hwang SH; Jang S; Park CJ; Seo EJ; Lee JH
Br J Haematol; 2022 Aug; 198(4):703-712. PubMed ID: 35612271
[TBL] [Abstract][Full Text] [Related]
6. LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.
Kaastrup K; Gillberg L; Mikkelsen SU; Ørskov AD; Schöllkopf C; Mortensen BK; Porse B; Hansen JW; Grønbæk K
Clin Epigenetics; 2023 May; 15(1):91. PubMed ID: 37237325
[TBL] [Abstract][Full Text] [Related]
7. A Lower Frequency of Spliceosome Mutations Distinguishes Clonal Cytopenias of Undetermined Significance From Low-Risk Myelodysplastic Syndromes, Despite Inherent Similarities in Genomic, Laboratory, and Clinical Features.
Ferrone CK; McNaughton AJM; Rashedi I; Ring B; Buckstein R; Tsui H; Rauh MJ
Mod Pathol; 2023 Mar; 36(3):100068. PubMed ID: 36788103
[TBL] [Abstract][Full Text] [Related]
8. Morphologic, immunophenotypic, and molecular genetic comparison study in patients with clonal cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia with myelodysplasia-related changes: A single institution experience.
Gao L; Hyter S; Zhang D; Kelting S; Woodroof J; Abdallah AO; Yacoub A; McGuirk J; Abdelhakim H; Godwin AK; Cui W
Int J Lab Hematol; 2022 Aug; 44(4):738-749. PubMed ID: 35352484
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single-center analysis of 79 patients.
Dimopoulos K; Hansen OK; Sjö LD; Saft L; Schjødt IM; Werner Hansen J; Grønbaek K
Cytometry B Clin Cytom; 2020 May; 98(3):250-258. PubMed ID: 31479199
[TBL] [Abstract][Full Text] [Related]
10. The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance.
Brett VE; Lechevalier N; Trimoreau F; Dussiau C; Dimicoli-Salazar S; Coster L; Luquet I; Nadal N; Ribourtout B; Chapiro E; Lefebvre C; Tondeur S; Balducci E; Nguyen-Khac F; Borie C; Radford-Weiss I; Barin C; Eclache V; Mansier O; Bidet A;
Genes Chromosomes Cancer; 2023 Mar; 62(3):139-151. PubMed ID: 36412977
[TBL] [Abstract][Full Text] [Related]
11. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
[TBL] [Abstract][Full Text] [Related]
12. Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.
Jevremovic D; Nanaa A; Geyer SM; Timm M; Azouz H; Hengel C; Reberg A; He R; Viswanatha D; Salama ME; Shi M; Olteanu H; Horna P; Otteson G; Greipp PT; Xie Z; Alkhateeb HB; Hogan W; Litzow M; Patnaik MM; Shah M; Al-Kali A; Nguyen PL
Am J Clin Pathol; 2022 Oct; 158(4):530-536. PubMed ID: 35938646
[TBL] [Abstract][Full Text] [Related]
13. Prediction of risk for myeloid malignancy in clonal hematopoiesis.
Weeks LD; Niroula A; Neuberg D; Wong W; Lindsley RC; Luskin M; Berliner N; Stone RM; DeAngelo DJ; Soiffer R; Uddin MM; Griffin G; Vlasschaert C; Gibson CJ; Jaiswal S; Bick AG; Malcovati L; Natarajan P; Ebert BL
NEJM Evid; 2023 May; 2(5):. PubMed ID: 37483562
[TBL] [Abstract][Full Text] [Related]
14. Relationship between clone metrics and clinical outcome in clonal cytopenia.
Gallì A; Todisco G; Catamo E; Sala C; Elena C; Pozzi S; Bono E; Ferretti VV; Rizzo E; Molteni E; Zibellini S; Sarchi M; Boveri E; Ferrari J; Fiorelli N; Camaschella C; Gasparini P; Toniolo D; Cazzola M; Malcovati L
Blood; 2021 Sep; 138(11):965-976. PubMed ID: 34255818
[TBL] [Abstract][Full Text] [Related]
15. ICUS/CCUS/CHIP: basics & beyond.
Jain M; Tripathi A
Expert Rev Hematol; 2017 Oct; 10(10):915-920. PubMed ID: 28832236
[TBL] [Abstract][Full Text] [Related]
16. Flow Cytometric Findings in Clonal Cytopenia of Undetermined Significance.
Nirmalanantham P; Sakhi R; Beck R; Oduro K; Gadde R; Ryder C; Yoest J; Sadri N; Meyerson HJ
Am J Clin Pathol; 2022 Feb; 157(2):219-230. PubMed ID: 34542558
[TBL] [Abstract][Full Text] [Related]
17. Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?
Vobugari N; Heuston C; Lai C
Clin Adv Hematol Oncol; 2022 Jun; 20(6):375-383. PubMed ID: 35731608
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic Syndrome After Anti-CD19 Chimeric Antigen Receptor T-cell Therapy: A Case Series.
Dhaliwal A; Ravi S
Cureus; 2023 Sep; 15(9):e44677. PubMed ID: 37809221
[TBL] [Abstract][Full Text] [Related]
19. Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia.
El Hussein S; Evans AG; Fitzsimmons JM; Leong N; Buldo M; Segal JP; Jajosky AN; Rothberg PG; Liesveld JL; Oltvai ZN
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37160316
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostics in unclear cytopenia-How and when do we screen for clonal hematopoiesis?].
Haferlach C; Heuser M
Inn Med (Heidelb); 2022 Nov; 63(11):1141-1147. PubMed ID: 36121473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
